Literature DB >> 15063096

Animal models of obstetric complications in relation to schizophrenia.

Patricia Boksa1.   

Abstract

Epidemiological studies have provided strong evidence that exposure to obstetric complications is associated with an increased risk for later development of schizophrenia. These human studies have now begun to tease out which specific pregnancy, labor/delivery or neonatal complications might confer greatest risk for schizophrenia. Animal modeling can be a useful tool to directly ask if a particular obstetric complication can actually cause changes in brain function or behavior resembling changes in schizophrenia. This review describes currently available animal models for some of the obstetric complications with greatest effect size for schizophrenia, including maternal diabetes, preeclampsia, infection and stress during pregnancy, intrauterine growth retardation and fetal/neonatal hypoxia. Where available, evidence that these types of obstetric complications in animals produce alterations in CNS function or behavior, related to features of schizophrenic pathology, is presented. Animal models might provide insights into the mechanisms by which specific obstetric complications have long-term influence on brain development leading to increased risk for schizophrenia. Factors common to several obstetric complications associated with schizophrenia may also be discerned. In this way, animal modeling may provide the framework for human studies to ask further more refined questions concerning the role of specific obstetric factors contributing to schizophrenia, and may provide clues to prevention.

Entities:  

Mesh:

Year:  2004        PMID: 15063096     DOI: 10.1016/j.brainresrev.2004.01.001

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  35 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

Review 2.  The role of obstetric events in schizophrenia.

Authors:  Mary Catherine Clarke; Michelle Harley; Mary Cannon
Journal:  Schizophr Bull       Date:  2005-11-23       Impact factor: 9.306

3.  Of rats and schizophrenia.

Authors:  Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

4.  Normal birth weight variation is related to cortical morphology across the psychosis spectrum.

Authors:  Unn K Haukvik; Lars M Rimol; J Cooper Roddey; Cecilie B Hartberg; Elisabeth H Lange; Anja Vaskinn; Ingrid Melle; Ole A Andreassen; Anders Dale; Ingrid Agartz
Journal:  Schizophr Bull       Date:  2013-02-18       Impact factor: 9.306

Review 5.  Animal models of gene-environment interaction in schizophrenia: A dimensional perspective.

Authors:  Yavuz Ayhan; Ross McFarland; Mikhail V Pletnikov
Journal:  Prog Neurobiol       Date:  2015-10-25       Impact factor: 11.685

Review 6.  Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine system.

Authors:  Cecilia Flores
Journal:  J Psychiatry Neurosci       Date:  2011-09       Impact factor: 6.186

Review 7.  Sensorimotor gating deficits in "two-hit" models of schizophrenia risk factors.

Authors:  Asma Khan; Susan B Powell
Journal:  Schizophr Res       Date:  2017-10-22       Impact factor: 4.939

8.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

9.  Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.

Authors:  James P Kesby; Xiaoying Cui; Jonathan O'Loan; John J McGrath; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2009-11-18       Impact factor: 4.530

10.  Perinatal oxygen restriction does not result in reduced rat frontal cortex synaptophysin protein levels at adulthood as opposed to postmortem findings in schizophrenia.

Authors:  Carmit Nadri; Galila Agam
Journal:  J Mol Neurosci       Date:  2008-07-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.